AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Major Shareholding Notification 2022
Jun 28, 2022
61842_rns_2022-06-28_b1da9c30-16d5-4a68-a3e3-f08c9134bc95.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
==> picture [560 x 100] intentionally omitted <==
28 June,2022
To
BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Exchange Plaza, Towers, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai - 400 051 Scrip code: 541540 Scrip code: SOLARA
S. Murali Krishna
Company Secretary & Compliance Officer Solara Active Pharma Sciences Limited 2nd Floor, Admin Block, 27, Vandaloor, Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur Post, Chennai – 600127, Tamil Nadu
Dear Sir/ Madam,
Sub: Disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011- Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a)(ii)
Further to our intimation dated 01 June,2022 under regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (SAST Regulations), please find enclosed the form as prescribed under Regulation 10(6) of the SAST Regulations setting out the details of inter-se transfer of equity shares of Solara Active Pharma Sciences Limited, from Mr. Arun Kumar Pillai to Devicam Capital LLP, through an off-market transaction.
Kindly take the same on record.
Thanking you,
For Devicam Capital LLP
JYOTHINAGARA Digitally signed by JYOTHINAGARAVYASH VYASHA A SRIRAMAN SRIRAMAN RAMAPRASAD Date: 2022.06.28 RAMAPRASAD 15:52:30 +05'30' Jyothinagaravyasha Sriraman Ramaprasad Designated Partner DPIN:00173696
==> picture [560 x 100] intentionally omitted <==
Disclosures under Regulation 10(6) Report to Stock Exchanges in respect of any acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| 1. | Name of the Target Company (TC) | Name of the Target Company (TC) | Name of the Target Company (TC) | Solara Active Pharma Sciences Limited | Solara Active Pharma Sciences Limited | Solara Active Pharma Sciences Limited | |
|---|---|---|---|---|---|---|---|
| 2. | Name of the acquirer(s) | Devicam Capital LLP | |||||
| 3. | Name of the stock exchange where shares of the TC are listed |
BSE Limited (“BSE”) and National Stock Exchange of IndiaLimited(“NSE”) |
|||||
| 4. | Details of the transaction including rationale, if any, for the transfer/ acquisition of shares |
Inter-se transfer of equity shares among the promoter group through an off-market transaction. |
|||||
| 5. | Relevant regulation under which the acquirer is exempted from making open offer |
Regulation 10(1)(a)(ii) of the SAST Regulations | |||||
| 6. | Whether disclosure of proposed acquisition was required to be made under regulation 10 (5) and if so, -whether disclosure was made and whether it was made within the timeline specified under the regulations. -date of filing with the stock exchange |
-Disclosure was made within the timeline -Disclosure date-01 June,2022 |
|||||
| 7. | Details of acquisition | Disclosures required to be made under regulation 10(5) |
Whether the disclosures under regulation 10(5) are actually made |
||||
| a. | Name of the transferor / ~~seller~~ |
Mr. Arun Kumar Pillai | Yes | ||||
| b. | Date of acquisition | 22June,2022 | Yes | ||||
| c. | Number of shares/ voting rights in respect of the acquisitions from each person mentioned in 7(a) above |
Name of person | No of Equity Shares |
Yes |
|||
| Mr. Arun Kumar Pillai |
15,00, 000 |
||||||
| d. | Total shares~~proposed to be~~ ~~acquired~~/ actually acquired as a % of diluted share capital of TC |
4.17% | Yes |
==> picture [560 x 100] intentionally omitted <==
| e. | Price at which shares are~~proposed to~~ ~~be acquired~~/ actually acquired |
Rs. 408.90/- (Rupees Four Hundred and Eight Decimal Ninety Paise only) per share aggregating to Rs. 61,33,50,000/- (Rupees Sixty- One Crores Thirty-Three Lakhs Fifty Thousand Only) |
Rs. 408.90/- (Rupees Four Hundred and Eight Decimal Ninety Paise only) per share aggregating to Rs. 61,33,50,000/- (Rupees Sixty- One Crores Thirty-Three Lakhs Fifty Thousand Only) |
Yes |
Yes |
|
|---|---|---|---|---|---|---|
| 8. | Shareholding details | Pre-Transaction | Post-Transaction | |||
| No. of shares held |
% w.r.t total shar e capit al of TC |
No. of shares held |
% w.r.t total share capita l of TC |
|||
| A | ~~Acquirer/~~Transferee | |||||
| (i) |
Devicam Capital LLP | 1,51,546 | 0.42% | 16,51,546 | 4.59% | |
| B | ~~Seller/T~~ransferor | |||||
| (i) | Mr. Arun Kumar Pillai | 31,68,463 | 8.80% | 16,68,463 | 4.64% | |
| () Shareholding of each entity shall be shown separately and then collectively in a group. The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers. Signature: _ Jyothinagaravyasha Sriraman Ramaprasad Designated Partner Devicam Capital LLP DPIN:00173696 Bengaluru 28 June, 2022* JYOTHINAGARAV YASHA SRIRAMAN RAMAPRASAD Digitally signed by JYOTHINAGARAVYASHA SRIRAMAN RAMAPRASAD Date: 2022.06.28 15:53:35 +05'30' |
(*) Shareholding of each entity shall be shown separately and then collectively in a group. The above disclosure shall be signed by the acquirer mentioning date & place. In case, there is more than one acquirer, the report shall be signed either by all the persons or by a person duly authorized to do so on behalf of all the acquirers.
JYOTHINAGARAV Digitally signed by JYOTHINAGARAVYASHA YASHA SRIRAMAN SRIRAMAN RAMAPRASAD Date: 2022.06.28 15:53:35 RAMAPRASAD +05'30' Signature: _ Jyothinagaravyasha Sriraman Ramaprasad Designated Partner Devicam Capital LLP DPIN:00173696
Bengaluru 28 June, 2022